Kaiser Permanente
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Kaiser Permanente sits in the top decile of US sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count).
Kaiser Permanente: 294 sponsored US clinical trials, 21 recruiting.
Kaiser Permanente sponsors 294 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 228 completed. 28 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 6 trials.
Top-decile sponsor footprint
Kaiser Permanente ranks in the top decile of sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 238 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
294 total, page 4 of 6
Getting in Balance: A Workplace Diabetes Prevention Intervention Trial
NCT02589873
Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects
NCT02302196
Investigating Sedentary Time in Aging: New Directions
NCT02670369
Walk On! Physical Activity Coaching
NCT02478359
Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO
NCT02461745
PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention
NCT02346162
Patient Activation to Address Chronic Pain and Opioid Management in Primary Care
NCT02290223
The Northwest Coalition for Primary Care Practice Support
NCT02839382
Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
NCT02448550
CBT Insomnia Teens: Augmenting SSRIs to Improve Youth Depression
NCT02290496
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection
NCT02343822
Promoting Oral Health Among Smokers Randomized Trial
NCT02347124
Evaluating the Impact of a Value-based Prescription Drug Formulary
NCT04904055
Electronic Support for Pulmonary Embolism Emergency Disposition
NCT03601676
The CREATE Wellness Study
NCT02302612
Impact of Automated Education and Follow-up Mechanisms on Patient Engagement
NCT02279901
My Mobile Advice Program: A Randomized Pilot Feasibility Study
NCT02136498
Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy
NCT02056431
The Virtual Visit for Women With Gestational Diabetes
NCT02960295
SPREAD-NET: PRactices Enabling Adapting and Disseminating in the Safety NET
NCT02325531
Eat Out With KP: A Pilot to Improve the Impact of Dietary Advice for Families
NCT02124135
Pain Program for Active Coping & Training
NCT02113592
Appropriate Gestational Weight Gain in Overweight/Obese Women
NCT02130232
Artegraft Versus Propaten Dialysis Grafts
NCT02099344
Effectiveness of the Quotient® ADHD Assessment in a System of Care
NCT02094612
A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration
NCT01929460
Clinical Implementation of Carrier Status Using Next Generation Sequencing
NCT01902901
Vaccine Social Media Randomized Intervention Trial
NCT01873040
Community-based Interventions to Increase HIV Testing and HIV Care Utilization
NCT01867177
Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)
NCT01892592
The KP Personal Shopper: A Pilot to Improve the Impact of Dietary Advice
NCT01837524
Pain Program for Active Coping & Training
NCT01888146
Strategies and Opportunities to Stop Colon Cancer in Priority Populations
NCT01742065
Effects of a Patient Driven Assessment Process With Complex Pain Patients
NCT02746354
Effectiveness of Influenza Vaccine Reminder Systems
NCT01852656
PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER) Specific Aim 3b
NCT01890525
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
NCT01634126
Now Matters Now: An Online Suicide Prevention Program
NCT01924936
Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain
NCT01467843
Vaccine Hesitancy Intervention--Provider (VHIP)
NCT01667354
Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
NCT01582841
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879
Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist
NCT01776203
Cessation Service Use and Effectiveness for Hospitalized Smokers
NCT01236079
Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose Tolerance
NCT01489163
Telephone Counseling for Tobacco Cessation
NCT01489579
Considering Healthier Drinking Options in Collaborative Care
NCT01400581
Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System
NCT01952119
MoodHelper: Internet Cognitive Behavioral Therapy (CBT) for Depression
NCT01379027
Behavioral Activation for Perinatal Depression
NCT01401231
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 21 |
| Phase 3 | 20 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Kaiser Permanente pipeline
21 recruiting of 294 indexed (7% open); 228 completed (78%).
Phase mix: 28 late (III/IV) vs 27 early (I/II) (balanced across stages).
Top condition: Depression (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kaiser Permanente: open-pipeline peers nationwide
Peers matched on 294 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Kaiser Permanente sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 294 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Mannkind Corporation · 7% recruiting · 42 trials
- Minneapolis Veterans Affairs Medical Center · 7% recruiting · 28 trials
Related
What to do with this Kaiser Permanente page
294 registered trials is a research-attention snapshot, not an endorsement of Kaiser Permanente or any single study.
- 21 of Kaiser Permanente's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Kaiser Permanente studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kaiser Permanente pipeline card: 294 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.